Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Analysis of treatment-resistant schizophrenia and 384 markers from candidate genes.

Pharmacogenetics and genomics - 1 Nov 2012

Teo Celine, Zai Clement, Borlido Carol, Tomasetti Carmine, Strauss John, Shinkai Takahiro, Le Foll Bernard, Wong Albert, Kennedy James L, De Luca Vincenzo

Abstract excerpt

The treatment of patients with schizophrenia who fail to respond to antipsychotics is a major challenge and the proportion of treatment-resistant patients is estimated to be 20 to 40%. There are few genetic association studies that have compared resistant versus non-resistant schizophrenic patients; however, many genetic association studies focusing on antipsychotic response have been published. This contribution...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Drug Resistance

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Frequency

Share to Genetic Markers

Share to Genetic Predisposition to Disease

Share to Phenotype

Share to Schizophrenia

Source

Identifiers

PMID: 23047292
DOI: 10.1097/FPC.0b013e3283586c04

Genes

NALCN

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Analysis of treatment-resistant schizophrenia and 384 markers from candidate genes.PMID 23047292Read ↗

Genome-wide association analysis of treatment resistant schizophrenia for variant discovery and polygenic assessmentSemantic proximity Read ↗

Interaction Testing and Polygenic Risk Scoring to Estimate the Association of Common Genetic Variants With Treatment Resistance in Schizophrenia.Semantic proximity Read ↗

Genome-wide association analysis of treatment resistant schizophrenia for variant discovery and polygenic assessment.Semantic proximity Read ↗

Polymorphisms in Schizophrenia-Related Genes Are Potential Predictors of Antipsychotic Treatment Resistance and Refractoriness.Semantic proximity Read ↗

Toward understanding genetic risk for differential antipsychotic response in individuals with schizophreniaSemantic proximity Read ↗

A genetic locus in 7p12.2 associated with treatment resistant schizophrenia.Semantic proximity Read ↗

The identification of novel genetic variants associated with antipsychotic treatment response outcomes in first-episode schizophrenia patients.Semantic proximity Read ↗

Treatment-Resistant Schizophrenia, Clozapine Resistance, Genetic Associations, and Implications for Precision Psychiatry: A Scoping ReviewSemantic proximity Read ↗

Polygenic overlap between schizophrenia risk and antipsychotic response: a genomic medicine approach.Semantic proximity Read ↗

Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics.Semantic proximity Read ↗

Increased Prevalence of Rare Copy Number Variants in Treatment-Resistant PsychosisSemantic proximity Read ↗

Increased rare duplication burden genomewide in patients with treatment-resistant schizophreniaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.